Moderna Inc. has signed a deal with a Uruguayan pharmaceutical company in a bid to expand its reach across Latin America.
The Covid-19 vaccine maker announced the distribution deal Tuesday with Adium Pharma SA to market the shots in 18 countries in the region including Brazil and Mexico. The shots will be supplied from Moderna’s plants in the U.S. and Europe, said Roman Saglio, head of commercial alliances for Latin America.
